Randall-type monoclonal immunoglobulin deposition disease: description of cardiac involvement
A Ramonatxo(Université de Poitiers), Frank Bridoux(Université de Poitiers), L Christiaens(Centre Hospitalier Universitaire de Poitiers), Éstelle Desport(Centre Hospitalier Universitaire de Poitiers), Sébastien Levesque(Centre hospitalier universitaire de Québec), Nicolas Bidegain(Université de Poitiers), Bruno Degand(Centre Hospitalier Universitaire de Poitiers), Florent Joly, R. Ortiz García(Université de Poitiers), Claire Bouleti(Inserm)
Cited by 2
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520